Abstract:
The current learning methodologies applied in organizations are often too generic and not
tailored to the specific learning needs of employees and their roles within the organization,
which can lead to inadequate training and compliance issues. This is particularly critical in
the pharmaceutical industry due to the stringent requirements for employee training in a
highly regulated environment. Consequently, developing a strategic, role-based learning
(RBL) approach has become a major focus in the industry. Boehringer Ingelheim,
highlighted in this case study, intends to adopt this approach and despite some working
areas having localized practices, the company seeks to establish a thorough role-based
learning framework. This effort involves tackling current challenges in documenting
Standard Operating Procedures (SOPs), defining roles, establishing adequate curricula, and
addressing infrastructure issues within existing systems.
The methodology involved contacting various subject matter experts on different subtopics
related to the main issue. These experts were interviewed through semi-structured
interviews, and the data was analyzed based on emerging themes. By investigating its
implementation at Boehringer Ingelheim, the study aims to identify key components that
contribute to an effective role-based learning strategy and the recommendations section
offers a step-by-step guide to refining and improving the implementation strategy. The
findings offer valuable insights for enhancing learning systems in the industry. The study
concludes that a role-based learning approach benefits pharmaceutical companies by
i
supporting compliance with regulatory requirements, increasing productivity, and avoiding
warning letters. Effective implementation requires structured organization, clear
communication, and stakeholder cooperation.